NDC 0270-7400

Iomeron

Iomeprol Injection

Iomeron is a Intravascular Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bracco Diagnostics Inc. The primary component is Iomeprol.

Product ID0270-7400_1e48b8c9-1afc-47d6-bc33-47b81510e6c3
NDC0270-7400
Product TypeHuman Prescription Drug
Proprietary NameIomeron
Generic NameIomeprol Injection
Dosage FormInjection, Solution
Route of AdministrationINTRAVASCULAR
Marketing Start Date2022-07-01
Marketing CategoryUNAPPROVED DRUG FOR USE IN DRUG SHORTAGE /
Labeler NameBRACCO DIAGNOSTICS INC
Substance NameIOMEPROL
Active Ingredient Strength816 mg/mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0270-7400-10

10 BOTTLE, GLASS in 1 BOX (0270-7400-10) > 100 mL in 1 BOTTLE, GLASS
Marketing Start Date2022-07-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Iomeron" or generic name "Iomeprol Injection"

NDCBrand NameGeneric Name
0270-7250IomeronIomeprol Injection
0270-7300IomeronIomeprol Injection
0270-7350IomeronIomeprol Injection
0270-7400IomeronIomeprol Injection
0270-9300IomeronIomeprol Injection
0270-9350IomeronIomeprol Injection
0270-9400IomeronIomeprol Injection
76381-725IomeronIomeprol Injection
76381-730IomeronIomeprol Injection
76381-735IomeronIomeprol Injection
76381-740IomeronIomeprol Injection
76381-930IomeronIomeprol Injection
76381-935IomeronIomeprol Injection
76381-940IomeronIomeprol Injection

Trademark Results [Iomeron]

Mark Image

Registration | Serial
Company
Trademark
Application Date
IOMERON
IOMERON
90597167 not registered Live/Pending
BRACCO SUISSE S.A.
2021-03-23
IOMERON
IOMERON
86104011 4616323 Live/Registered
Bracco Suisse S.A.,
2013-10-29
IOMERON
IOMERON
79032370 3318794 Dead/Cancelled
BRACCO SUISSE S.A.
2006-04-05
IOMERON
IOMERON
75599485 2340462 Dead/Cancelled
BRACCO S.p.A.
1998-12-04
IOMERON
IOMERON
74144750 1704511 Dead/Cancelled
BRACCO INDUSTRIA CHIMICA S.p.A.
1991-03-05
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.